First-in-man experience with a new 7F vascular closure device (EXOSEAL ^™): The 7F eclipse study

Keyphrases

• Ambulation 100%
• First-in-man 100%
• Men's Experiences 100%
• Vascular Closure Device 100%
• Time to Hemostasis 100%
• Adverse Events 50%
• Access Site Complications 50%
• Interventional Procedures 25%
• Hemostasis 25%
• United States 25%
• Low Dose Rate 25%
• Procedural 25%
• Diagnostic Procedures 25%
• Percutaneous Technique 25%
• Diabetic 25%
• Safety Profile 25%
• Primary Safety 25%
• Hematoma 25%
• Device Success 25%
• Mechanical Compression 25%
• Patient Comfort 25%
• Manual Compression 25%
• Procedural Success 25%
• Safety Endpoints 25%
• Access Site 25%
• Introducer Sheath 25%
• Early Ambulation 25%
• Deployment Profile 25%
• In(III) 25%

Medicine and Dentistry

• Blood Stasis 100%
• Mobilization 100%
• Adverse Event 40%
• Diagnosis 20%
• Diabetes Mellitus 20%
• Carvedilol 20%
• Hematoma 20%
• Patient Comfort 20%
• Introducer Sheath 20%